ELISA for Bensulfuron-Methyl
J. Agric. Food Chem., Vol. 50, No. 7, 2002 1793
(CDCl3): δ 7.81 (d, 1H, J ) 7.5 Hz, Ar), 7.53-7.37 (m, 3H, Ar), 5.64
CH2CH2COOH), 1.52 (m, 2H, OCH2CH2CH2CH2CH2COOH), 1.37 (m,
2H, OCH2CH2CH2CH2CH2COOH). Low FAB (+)-MS, m/z 511.14 [M
+ H]+.
(s, 2H, CH2SO2), 3.89 (s, 3H, COOCH3).
The compound 12 (695 mg, 2.80 mmol) was dissolved in 30 mL of
ethyl acetate, and the solution was cooled on an ice bath. Tert-
butylamine (409 mg, 5.60 mmol) was added slowly to the solution.
The resulting white suspension was stirred at 0 °C for 1 h, and the
stirring was continued at room temperature for 2 h. The mixture was
washed with 30 mL of 5% hydrochloric acid. The organic layer was
dried over anhydrous magnesium sulfate and evaporated under reduced
pressure to give 440 mg of compound 13 as a white solid: TLC (ethyl
acetate/n-hexane, 1:1, v/v) Rf, 0.73.
Hapten-4,4-({[2-(methoxycarbonyl)benzyl]sulfonyl}amino)-4-oxobu-
tanoic acid. To 1 mL of trifluoroacetic acid was added the compound
13 (300 mg, 1.05 mmol). The mixture was stirred at room temperature
for 3 h and then evaporated to dryness. To the residue was added 30
mL of distilled water, and the mixture was extracted with ethyl acetate
(2 × 30 mL). The combined organic layer was dried over anhydrous
magnesium sulfate and concentrated on a rotary evaporator under
reduced pressure. The residue was recrystallized from ethyl acetate to
give 255 mg of compound 18 as a white solid: TLC (methylene
chloride/methanol, 1:9, v/v) Rf, 0.8. 1H NMR (CDCl3): δ 8.01 (d, 1H,
J ) 7.5 Hz, Ar), 7.61-7.40 (m, 3H, Ar), 4.90 (s, 2H, CH2SO2), 4.56
(s, 2H, SO2NH2), 3.94 (s, 3H, OCH3).
The hydrolysis of compound 13 (440 mg, 1.62 mmol) was conducted
in 20 mL of tetrahydrofuran (THF)/1 N NaOH mixture (1:1, v/v) at 65
°C for 5 h. THF was removed on a rotary evaporator under reduced
pressure. The alkaline solution was acidified with 20 mL of 5%
hydrochloric acid, and then extracted with ethyl acetate (2 × 30 mL).
The combined organic layer was dried over anhydrous magnesium
sulfate and concentrated on a rotary evaporator to give 270 mg of
compound 14 as a white solid: TLC (ethyl acetate/n-hexane, 1:1, v/v)
Hapten-4 was synthesized according to a method introduced by
Schlaeppi et al. (12). To 5 mL of acetonitrile was added 200 mg (0.87
mmol) of methyl-(aminosulfonyl)-o-toluate, compound 18, together with
87 mg (0.87 mmol) of succinic anhydride. Then, 265.5 mg (1.74 mmol)
of 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) was added dropwise for
10 min under slightly cooled conditions (22 °C). After this was stirred
for 2 h, the resulting solution was poured into 50 mL of distilled water
and washed with 50 mL of ethyl acetate to remove some impurities.
The organic layer was discarded, and the aqueous phase was acidified
to pH 2 with hydrochloric acid, and then extracted with ethyl acetate
(2 × 50 mL). The combined organic layer was dried over anhydrous
magnesium sulfate, the solvent was removed by evaporation, and the
residue was recrystallized from ethyl acetate to give 100 mg of hapten-4
as a white solid: TLC (methanol/methylene chloride/acetic acid, 1:9:
1
Rf, 0.22 (tailing). H NMR (CDCl3): δ 13.1 (br s, 1H, COOH), 7.81
(d, 1H, J ) 7.5 Hz, Ar), 7.53-7.37 (m, 3H, Ar), 4.88 (s, 2H, CH2-
SO2), 1.23 (s, 9H, NHC(CH3)3).
To a stirred solution of the compound 14 (1000 mg, 3.7 mmol) in
20 mL of acetonitrile were added 6-bromohexanoic acid (1008 mg,
5.6 mmol) and DBU (1127 mg, 7.4 mmol). After the reaction mixture
was heated at 50 °C for 1 h, it was concentrated on a rotary evaporator,
acidified with 30 mL of 5% hydrochloric acid, and extracted with ethyl
acetate (2 × 30 mL). The combined organic layer was dried over
anhydrous magnesium sulfate, and the solvent was removed on a rotary
evaporator. The residue was purified by using preparative TLC on silica
gel twice with methylene chloride/isopropyl alcohol mixture (9.5:0.5,
v/v) as a developing solvent to give 180 mg of compound 15 as a
white solid: TLC (methylene chloride/isopropyl alcohol, 9.5:0.5, v/v)
Rf, 0.4. 1H NMR (CDCl3): δ 7.91 (d, 1H, J ) 7.5 Hz, Ar), 7.60-7.30
(m, 3H, Ar), 4.88 (s, 2H, CH2SO2), 4.30 (m, 2H, OCH2CH2CH2CH2-
CH2COOH), 2.61 (br s, 1H, CH2SO2NH), 2.36 (m, 2H, OCH2CH2-
CH2CH2CH2COOH), 1.78 (m, 2H, OCH2CH2CH2CH2CH2COOH), 1.67
(m, 2H, OCH2CH2CH2CH2CH2COOH), 1.48 (m, 2H, OCH2CH2CH2-
CH2CH2COOH), 1.25 (s, 9H, NHC(CH3)3).
1
0.1, v/v/v) Rf, 0.47. H NMR (CD3OD): δ 7.91 (d, 1H, J ) 7.5 Hz,
Ar), 7.52-7.42 (m, 3H, Ar), 4.88 (s, 2H, CH2SO2), 3.85 (s, 3H, OCH3),
2.48 (m, 2H, COCH2CH2COOH), 2.43 (m, 2H, COCH2CH2COOH).
Low FAB (+)-MS, m/z 329.9 [M + H]+.
Hapten-5, ({({({[(4,6-dimethoxypyrimidin-2-yl)amino]carbonyl}-
amino)sulfonyl} methyl)benzoyl}amino)acetic acid. To a solution of
bensulfuron, the compound 2 (398 mg, 1 mmol) in dry N, N-
dimethylformamide (DMF) was added 1,1′-carbonyldiimidazole (CDI)
(172 mg, 1.06 mmol) at 0 °C. After the initial vigorous evolution of
gas, the reaction mixture (the temperature of which was allowed to
increase to room temperature) was stirred until no more gas evolved.
Solid ethyl glycinate hydrochloride (142 mg, 1.02 mmol) was added,
and the mixture was stirred until a clear solution resulted. On adding
water dropwise to this solution, a precipitate formed. The precipitate
was filtered out and the filtrate was concentrated under reduced pressure
to afford a pale-yellow solid. It was column chromatographed on silica
gel using ethyl acetate/n-hexane mixture (1:2, v/v) as an eluent to afford
To 1 mL of trifluoroacetic acid was added the compound 15 (150
mg, 0.49 mmol). The mixture was stirred at room temperature for 2 h
and then evaporated to dryness. Water (30 mL) was added to the
residue, and the mixture was extracted with ethyl acetate (2 × 30 mL).
The combined organic layer was dried over anhydrous magnesium
sulfate and concentrated on a rotary evaporator. The residue was purified
by using a chromatotron using ethyl acetate/n-hexane mixture (1:1, v/v)
as an eluent to give 113 mg of a transparent oily compound 16: TLC
1
compound 20 (213 mg, 74.9%): mp 165 °C. H NMR (CDCl3): δ
9.30 (br s, 1 H), 7.17 (br s, 1 H), 5.70 (s, 1 H), 4.26-4.18 (m, 4 H),
3.94 (s, 6 H), 1.08 (t, J ) 7.10 Hz, 3 H). 13C NMR (75.47 MHz,
CDCl3): δ 179.39, 168.21, 154.75, 151.23, 67.34, 54.34, 51.20, 37.91,
14.68. IR (vmax, KBr) 1723, 1610, 1454.
1
(methylene chloride/methanol, 1:9, v/v) Rf, 0.8. H NMR (CDCl3) δ
7.91 (d, 1H, J ) 7.5 Hz, Ar), 7.52 (m, 2H, Ar), 7.42 (m, 1H, Ar), 4.88
(s, 2H, CH2SO2), 4.85 (s, 2H, CH2SO2NH2), 4.32 (t, 2H, J ) 7 Hz,
OCH2CH2CH2CH2CH2COOH), 2.36 (m, 2H, OCH2CH2CH2CH2CH2-
COOH), 1.78 (m, 2H, OCH2CH2CH2CH2CH2COOH), 1.67 (m, 2H,
OCH2CH2CH2 CH2CH2COOH), 1.48 (m, 2H, OCH2CH2CH2CH2CH2-
COOH).
A solution of the compound 20 (103 mg, 0.29 mmol) in THF (5
mL) was cooled to 5 °C. To this solution was slowly added lithium
hydroxide monohydrate (36 mg, 0.86 mmol) in water (0.9 mL). The
resulting solution was stirred at 5-10 °C for 1.5 h and then diluted
with 1 N hydrochloric acid (0.86 mL). The mixture was concentrated
under reduced pressure to give the crude product. It was chromato-
graphed on silica gel using methanol/chloroform mixture (1:3, v/v) as
an eluent to afford hapten-5 (32 mg, 35%) as a pale-yellow crystalline
To a stirred solution of the compound 16 (113 mg, 0.37 mmol) in
4 mL of acetonitrile were added phenyl (4,6-dimethoxypyrimidin-2-
yl)carbamate (101 mg, 0.37 mmol) and DBU (113 mg, 0.74 mmol).
The reaction mixture was stirred at room temperature for 1 h, diluted
with 30 mL of ethyl acetate, and washed with 30 mL of water. The
organic layer was discarded, and the aqueous layer was acidified to
pH 3 with 5% hydrochloric acid, and then extracted with ethyl acetate
(2 × 30 mL). The combined organic layer was dried over anhydrous
magnesium sulfate, the solvent was removed by evaporation under
reduced pressure, and the residue was recrystallized from ethyl acetate/
n-hexane mixture to give 97 mg of compound 17 (hapten-3) as a white
solid: TLC (methanol/methylene chloride/acetic acid, 1:9:0.1, v/v/v)
Rf, 0.56. 1H NMR (DMSO-d6): δ 7.81 (d, 1H, J ) 7.5 Hz, Ar), 7.60-
7.40 (m, 3H, Ar), 5.92 (s, 1H, pyrimidine H), 5.29 (s, 2H, CH2SO2),
4.18 (m, 2H, OCH2CH2CH2CH2CH2COOH), 3.66 (s, 6H, OCH3), 2.21
(m, 2H, OCH2CH2CH2CH2CH2COOH), 1.65 (m, 2H, OCH2CH2CH2-
1
solid: mp 220 °C. H NMR (DMSO-d6): δ 9.30 (br s, 1H), 7.17 (br
s, 1H), 5.70 (s, 1H), 4.26-4.19 (m, 2H), 3.94 (s, 6H). 13C NMR (75.47
MHz, DMSO-d6): δ 171.87, 168.12, 154.75, 151.23, 69.73, 56.43,
38.76. IR (vmax, KBr) 3400-2460, 1714, 1456. Low FAB (+)-MS,
m/z 257 [M + H]+.
Hapten-6, 4-(3-(4,6-dimethoxypyrimidin-2-yl)-5-{[2-(methoxycar-
bonyl)benzyl] sulfonyl}-4-oxo-1,3,5-triazinan-1-yl)butanoic acid and
Hapten-7, 6-(3-(4,6-dimethoxypyrimidin-2-yl)-5-{[2-{methoxycarbonyl}-
benzyl]sulfonyl}-4-oxo-1,3,5-triazinan-1-yl)hexanoic acid. A mixture
of bensulfuron-methyl (2.1 g, 5.0 mmol), 4-aminobutyric acid (0.52 g,
5.0 mmol) for the synthesis of hapten-6 or 6-aminohexanoic acid (0.66
g, 5.0 mmol) for synthesis of hapten-7, and formaldehyde (35%, 5.6